ANCA-associated vasculitides

Clinical trials for ANCA-associated vasculitides explained in plain language.

Never miss a new study

Get alerted when new ANCA-associated vasculitides trials appear

Sign up with your email to follow new studies for ANCA-associated vasculitides, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Can extra rituximab keep vasculitis at bay?

Disease control Completed

This study looked at whether giving rituximab for 46 months instead of the usual 18 months can better prevent relapses of ANCA-associated vasculitis, a rare autoimmune disease that causes blood vessel inflammation. 97 patients who were already in remission after initial rituximab…

Matched conditions: ANCA-ASSOCIATED VASCULITIDES

Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC

ANCA-associated vasculitides

Get alerted when new ANCA-associated vasculitides trials appear

Can extra rituximab keep vasculitis at bay?